NuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.56, in-line with the analyst estimate of $0.56. Revenue for the quarter came in at $271.7 million versus the consensus estimate of $272.64 million.

Fourth Quarter 2017 Highlights:

• Revenue remained flat at $271.7 million compared to prior year, with strong international growth of 34% on a constant currency basis;
• GAAP operating profit margin of 11.0%; Non-GAAP operating profit margin of 18.2%; and
• GAAP diluted earnings per share of $0.46; Non-GAAP diluted earnings per share increase of 5.7% to $0.56.

Full Year 2017 Highlights:

• Revenue increased to $1,029.5 million, or 7.0% on a reported and constant currency basis;
• GAAP operating profit margin of 11.0%; Non-GAAP operating profit margin up 50 basis points to 16.6%; and
• GAAP diluted earnings per share of $1.50; Non-GAAP diluted earnings per share increase of 15.1% to $1.91.

For earnings history and earnings-related data on NuVasive (NUVA) click here.